Skip to content

Archive

Category: Prescription Drugs

Madely Health Headlines Commentary for March 27, 2013

Source:

Drug reactions send 26,000 seniors to hospital

Reference:

 

Downlaod CIHI report here

Madely Health Headlines Commentary for March , 2013

Source:

Excellent Results For MS Drug “Plegridy”

Reference:

The results were presented at the American Academy of Neurology’s 65th Annual Meeting. It is not published.

Further it compares the drug to placebo, a useless marker for clinicians. We want to know how it fares against other medication of a similar class at least and how it compares to other medication in use today.  It also refers to relative and not absolute risk reduction.

Madely Health Headlines Commentary for March 11, 2013

Source:

New wave of ‘superbugs’ poses dire threat, says chief medical officer

 

Madely Health Headlines Commentary for February , 2013

 

Madely Health Headlines Commentary for January 29, 2013

Source:

New antibiotics are a matter of life or death

 

Madely Health Headlines Commentary for January 10, 2013

Source:

Scandal of the poison pen-pushers: How doctors and patients are kept in the dark about potentially dangerous everyday drugs

 

Madely Health Headlines Commentary for December 18, 2012

Source:

Dangers Of Prescribing ADD Medication To Healthy Patients

Reference:

Cynthia Forlini, Serge Gauthier, and Eric Racine
Should physicians prescribe cognitive enhancers to healthy individuals?
CMAJ cmaj.121508; published ahead of print December 17, 2012

Madely Health Headlines Commentary for November 28, 2012

Source:

4 foods to avoid while taking medication

 

Madely Health Headlines Commentary for November 7, 2012

Source:

Men May Benefit From Osteoporosis Drug, Too: Study

Reference:

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

Madely Health Headlines Commentary for November 5, 2012

Source:

Mixing drugs and herbal remedies may pose a major health risk, researchers warn

Reference:

Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review

Madely Health Headlines Commentary for October 22, 2012

Source:

More than 250 drugs remain in short supply

Madely Health Headlines Commentary for October 16, 2012

Source:

Abbott Labs rises on hepatitis C drug data

Reference:

This press release does not cite published studies. Nor do we know if there were negative outcomes in other clinical trials. THere is no obligation on the part of pharma to release details of stiudies that cast a negative outcome for their product.

 

Madely Health Headlines Commentary for October 3, 2012

Source:

Breast cancer treatment targets tumours with few side effects

Reference:

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Madely Health Headlines Commentary for September 10, 2012

Source:

Risk averted — hormone therapy regains support

 

Madely Health Headlines Commentary for August 1, 2012

Source:

Science takes tiny steps toward a cure for AIDS

 

Madely Health Headlines Commentary for July 26, 2012

Source:

The Fraser Institute: Canadians Wait Almost Twice as Long as Americans for New, Life-Saving Cancer Drugs

 

Madely Health Headlines Commentary for July 18, 2012

Source:

Second Diet Drug Wins FDA Approval

 

Madely Health Headlines Commentary for July 12, 2012

Source:

OxyContin Remake Sends Abusers to Other Opioids

Reference:

Cicero TJ, et al “Effect of abuse-deterrent formulation of OxyContin” N Engl J Med 2012; 367(2): 187-189.

Madely Health Headlines Commentary for March 9, 2012

Source:

Donepezil For Treatment Of Moderate To Severe Alzheimer’s

Reference:

“Donepezil and Memantine for Moderate-to-Severe Alzheimer’s Disease”
Robert Howard, M.D., Rupert McShane, F.R.C.Psych., James Lindesay, D.M.et.al.,
New England Journal Of Medicine, March 2012, dpi:366:893-903

Madely Health Headlines Commentary for March 1, 2012

 

 

Source:

Pills as good as stents for some patients: study

Reference:

Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease

Madely Health Headlines Commentary for February 29, 2012

Source:

FDA Warns on Statin Drugs

 

Madely Health Headlines Commentary for February 28, 2012

 

 

Source:

Sleeping Pill Death Toll May Top 500,000

Madely Health Headlines Commentary for January 25, 2012

Source:

Drug may help slow prostate tumour growth

Reference:

The Lancet: Dutasteride in localised prostate cancer management

Madely Health Headlines Commentary for November 29, 2011

Source:

Ottawa doc calls for end to rich hospital parking fees

Avastin no longer OK for metastatic breast cancer

Blood clot risk higher with some types of pill

Madely Health Headlines Commentary for September 14, 2011

Source:

FDA Panel Backs Xarelto for Stroke Prevention

 

Madely Health Headlines Commentary for July 28, 2011

Source:

Ten Top-Selling Drugs Coming Off Patent

 

FDA Panel Endorses Novel Drug for Lymphoma

Madely Health Headlines Commentary for April 27, 2011

Source:

Painkillers and antidepressants might make a bad mix

Reference:

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Madely Health Headlines Commentary for April 25, 2011

Source:

New birth-control pills can triple the risk of blood clots

Reference:

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database

 

 

 

 

New generation of blood thinners offers patients easier-to-use options

Madely Health Headlines Commentary for April 1, 2011

Source:

Can Mom’s Medicine Hurt the Baby?: Few Studies Detail Prescription Drugs’ Risk to Pregnant, Breast-Feeding Women

Madely Health Headlines Commentary for March 9, 2011

Source:

Ontario Health Minister won’t help mom get breast-cancer drug

Madely Health Headlines Commentary for February 21, 2011

Source:

Common birth control pill not tied to heart attacks

Reference:

Progestogen-Only Contraceptives and the Risk of Acute Myocardial Infarction: A Meta-Analysis

Madely Health Headlines Commentary for February 2, 2011

Source:

Avastin Linked to Fatal Side Effects

Madely Health Headlines Commentary for January 20, 2011

Source:

Drug to Fight Melanoma Prolonged Life in Trial

Madely Health Headlines Commentary for January 14, 2011

Source:
FDA Restricts Acetaminophen in Some Products

Madely Health Headlines Commentary for December 20, 2010

Source: Report warns of medication shortages across Canada Reference: Canadian Pharmacists Association drug shortage report

Madely Health Headlines Commentary for November 18, 2010

Source:
Breast cancer risk of hormone therapy overblown, group says

Reference:

Misinformation. Misinterpretation. Missed opportunity

Madely Health Headlines Commentary for November 12, 2010

Source:

Acne drug not found to increase suicide risk

Reference:

Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

Madely Health Headlines Commentary for October 15 , 2010

Source:

Sanofi Says MS Drug Reduces Relapses

MS Society members ‘break ranks’ and try treatment

Madely Health Headlines Commentary for June 16, 2010

Source:

Some blood pressure drugs may increase cancer risk, study suggests

Reference:

Blood pressure pills ‘cancer link’

Madely Health Headlines Commentary for June 9, 2010

Source:

FDA: MS Drug Effective, But Has ‘Safety Issues’

Madely Health Headlines Commentary for March 24, 2010

Source:Study adds evidence that bone drugs work, are safe

Reference:

Evolving Data about Subtrochanteric Fractures and Bisphosphonates

Madely Health Headlines Commentary for March 19, 2010

Source:

Seniors’ prescription drug use rises

Reference:

Nearly two-thirds of seniors using five or more types of prescription drugs

Madely Health Headlines Commentary for March 12, 2010

Source:
Birth-Control Pills Cut Cancer, Lengthen Women’s Lives in Study

Reference:
Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study

Madely Health Headlines Commentary for February 10, 2010

Source:

Paxil, Tamoxifen May Be a Risky Combo

Reference:

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

Madely Health Headlines Commentary for February 2, 2010

Source:

Hidden Dangers of Herbal Meds Reviewed

Reference:

Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases

Comment:

There is excellent web site that reviews the scientific evidence for the efficacy of herbal remedies from an independent assessment perspective. It also evaluates the quality and ingredients of many products in stores with respect to labelling accuracy and ingredient composition. The web site is consumerlab.com.

Madely Health Headlines Commentary for January 25, 2010

Source:

Many parents unaware of the risks of vitamins

Reference:

Safety Considerations and Potential Interactions of Vitamins: Should Vitamins Be Considered Drugs?